Stock Screener · Library
Bicycle Therapeutics plc financial statement history
Source-linked financial facts for Bicycle Therapeutics plc with exact reported periods, units and filing dates. Historical periods ending 2021–2025.
What this record covers
This historical reference uses a locally cached SEC companyfacts snapshot and reports periods ending from 2021 through 2025. It is not a current quotation feed, a screening recommendation or a verification of the company's present condition.
Each value retains its reported unit and exact period. Filing fiscal year describes the submitting filing and can differ from the year of a comparative fact. Values with different currencies or period boundaries are not combined.
Total assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 479792000 | USD | 2023-02-28 | 2022 / FY | us-gaap:Assets | 10-K · 0001558370-23-002238 |
| As of 2022-12-31 | 410609000 | USD | 2024-02-20 | 2023 / FY | us-gaap:Assets | 10-K · 0001558370-24-001324 |
| As of 2023-12-31 | 595344000 | USD | 2025-02-25 | 2024 / FY | us-gaap:Assets | 10-K · 0001558370-25-001438 |
| As of 2024-12-31 | 956868000 | USD | 2026-03-17 | 2025 / FY | us-gaap:Assets | 10-K · 0001104659-26-028971 |
| As of 2025-12-31 | 717597000 | USD | 2026-03-17 | 2025 / FY | us-gaap:Assets | 10-K · 0001104659-26-028971 |
Current assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 458555000 | USD | 2023-02-28 | 2022 / FY | us-gaap:AssetsCurrent | 10-K · 0001558370-23-002238 |
| As of 2022-12-31 | 369383000 | USD | 2024-02-20 | 2023 / FY | us-gaap:AssetsCurrent | 10-K · 0001558370-24-001324 |
| As of 2023-12-31 | 561868000 | USD | 2025-02-25 | 2024 / FY | us-gaap:AssetsCurrent | 10-K · 0001558370-25-001438 |
| As of 2024-12-31 | 928605000 | USD | 2026-03-17 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001104659-26-028971 |
| As of 2025-12-31 | 682885000 | USD | 2026-03-17 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001104659-26-028971 |
Cash and cash equivalents
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 438680000 | USD | 2024-02-20 | 2023 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001558370-24-001324 |
| As of 2022-12-31 | 339154000 | USD | 2025-02-25 | 2024 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001558370-25-001438 |
| As of 2023-12-31 | 526423000 | USD | 2026-03-17 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001104659-26-028971 |
| As of 2024-12-31 | 879520000 | USD | 2026-03-17 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001104659-26-028971 |
| As of 2025-12-31 | 628110000 | USD | 2026-03-17 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001104659-26-028971 |
Property, plant and equipment
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 3123000 | USD | 2023-02-28 | 2022 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001558370-23-002238 |
| As of 2022-12-31 | 19110000 | USD | 2024-02-20 | 2023 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001558370-24-001324 |
| As of 2023-12-31 | 14515000 | USD | 2025-02-25 | 2024 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001558370-25-001438 |
| As of 2024-12-31 | 9516000 | USD | 2026-03-17 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001104659-26-028971 |
| As of 2025-12-31 | 6021000 | USD | 2026-03-17 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001104659-26-028971 |
Total liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 133538000 | USD | 2023-02-28 | 2022 / FY | us-gaap:Liabilities | 10-K · 0001558370-23-002238 |
| As of 2022-12-31 | 139826000 | USD | 2024-02-20 | 2023 / FY | us-gaap:Liabilities | 10-K · 0001558370-24-001324 |
| As of 2023-12-31 | 224412000 | USD | 2025-02-25 | 2024 / FY | us-gaap:Liabilities | 10-K · 0001558370-25-001438 |
| As of 2024-12-31 | 163808000 | USD | 2026-03-17 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001104659-26-028971 |
| As of 2025-12-31 | 107620000 | USD | 2026-03-17 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001104659-26-028971 |
Current liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 36238000 | USD | 2023-02-28 | 2022 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001558370-23-002238 |
| As of 2022-12-31 | 53342000 | USD | 2024-02-20 | 2023 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001558370-24-001324 |
| As of 2023-12-31 | 69537000 | USD | 2025-02-25 | 2024 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001558370-25-001438 |
| As of 2024-12-31 | 67230000 | USD | 2026-03-17 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001104659-26-028971 |
| As of 2025-12-31 | 56984000 | USD | 2026-03-17 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001104659-26-028971 |
Long-term debt
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 29873000 | USD | 2023-02-28 | 2022 / FY | us-gaap:LongTermDebtNoncurrent | 10-K · 0001558370-23-002238 |
| As of 2022-12-31 | 30315000 | USD | 2024-02-20 | 2023 / FY | us-gaap:LongTermDebtNoncurrent | 10-K · 0001558370-24-001324 |
| As of 2023-12-31 | 30698000 | USD | 2025-02-25 | 2024 / FY | us-gaap:LongTermDebtNoncurrent | 10-K · 0001558370-25-001438 |
Stockholders equity
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 346254000 | USD | 2025-02-25 | 2024 / FY | us-gaap:StockholdersEquity | 10-K · 0001558370-25-001438 |
| As of 2022-12-31 | 270783000 | USD | 2026-03-17 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001104659-26-028971 |
| As of 2023-12-31 | 370932000 | USD | 2026-03-17 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001104659-26-028971 |
| As of 2024-12-31 | 793060000 | USD | 2026-03-17 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001104659-26-028971 |
| As of 2025-12-31 | 609977000 | USD | 2026-03-17 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001104659-26-028971 |
Revenue
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 11697000 | USD | 2024-02-20 | 2023 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001558370-24-001324 |
| 2022-01-01 to 2022-12-31 | 14463000 | USD | 2025-02-25 | 2024 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001558370-25-001438 |
| 2023-01-01 to 2023-12-31 | 26976000 | USD | 2026-03-17 | 2025 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001104659-26-028971 |
| 2024-01-01 to 2024-12-31 | 35275000 | USD | 2026-03-17 | 2025 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001104659-26-028971 |
| 2025-01-01 to 2025-12-31 | 72586000 | USD | 2026-03-17 | 2025 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001104659-26-028971 |
Research and development
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 44880000 | USD | 2024-02-20 | 2023 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001558370-24-001324 |
| 2022-01-01 to 2022-12-31 | 81609000 | USD | 2025-02-25 | 2024 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001558370-25-001438 |
| 2023-01-01 to 2023-12-31 | 156496000 | USD | 2026-03-17 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001104659-26-028971 |
| 2024-01-01 to 2024-12-31 | 172966000 | USD | 2026-03-17 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001104659-26-028971 |
| 2025-01-01 to 2025-12-31 | 240283000 | USD | 2026-03-17 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001104659-26-028971 |
Operating income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -65618000 | USD | 2024-02-20 | 2023 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001558370-24-001324 |
| 2022-01-01 to 2022-12-31 | -116653000 | USD | 2025-02-25 | 2024 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001558370-25-001438 |
| 2023-01-01 to 2023-12-31 | -189946000 | USD | 2026-03-17 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001104659-26-028971 |
| 2024-01-01 to 2024-12-31 | -209872000 | USD | 2026-03-17 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001104659-26-028971 |
| 2025-01-01 to 2025-12-31 | -247065000 | USD | 2026-03-17 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001104659-26-028971 |
Net income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -66819000 | USD | 2024-02-20 | 2023 / FY | us-gaap:NetIncomeLoss | 10-K · 0001558370-24-001324 |
| 2022-01-01 to 2022-12-31 | -112717000 | USD | 2025-02-25 | 2024 / FY | us-gaap:NetIncomeLoss | 10-K · 0001558370-25-001438 |
| 2023-01-01 to 2023-12-31 | -180664000 | USD | 2026-03-17 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001104659-26-028971 |
| 2024-01-01 to 2024-12-31 | -169031000 | USD | 2026-03-17 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001104659-26-028971 |
| 2025-01-01 to 2025-12-31 | -218960000 | USD | 2026-03-17 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001104659-26-028971 |
Diluted earnings per share
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -2.67 | USD/shares | 2024-02-20 | 2023 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001558370-24-001324 |
| 2022-01-01 to 2022-12-31 | -3.8 | USD/shares | 2025-02-25 | 2024 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001558370-25-001438 |
| 2023-01-01 to 2023-12-31 | -5.08 | USD/shares | 2026-03-17 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001104659-26-028971 |
| 2024-01-01 to 2024-12-31 | -2.9 | USD/shares | 2026-03-17 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001104659-26-028971 |
| 2025-01-01 to 2025-12-31 | -3.16 | USD/shares | 2026-03-17 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001104659-26-028971 |
Operating cash flow
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -14794000 | USD | 2024-02-20 | 2023 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001558370-24-001324 |
| 2022-01-01 to 2022-12-31 | -86111000 | USD | 2025-02-25 | 2024 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001558370-25-001438 |
| 2023-01-01 to 2023-12-31 | -60628000 | USD | 2026-03-17 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001104659-26-028971 |
| 2024-01-01 to 2024-12-31 | -164724000 | USD | 2026-03-17 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001104659-26-028971 |
| 2025-01-01 to 2025-12-31 | -249675000 | USD | 2026-03-17 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001104659-26-028971 |
Capital expenditure
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 2030000 | USD | 2024-02-20 | 2023 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001558370-24-001324 |
| 2022-01-01 to 2022-12-31 | 18987000 | USD | 2025-02-25 | 2024 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001558370-25-001438 |
| 2023-01-01 to 2023-12-31 | 2929000 | USD | 2026-03-17 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001104659-26-028971 |
| 2024-01-01 to 2024-12-31 | 1235000 | USD | 2026-03-17 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001104659-26-028971 |
| 2025-01-01 to 2025-12-31 | 2350000 | USD | 2026-03-17 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001104659-26-028971 |
Source and method
SEC public numeric facts are reorganized into a standard reference. Tag priority follows the native app's declared concept chains; the latest filed observation is selected within the same exact start, end and unit. A missing value stays missing. No currency, quarterly total, ratio, share-price series or dividend calendar is inferred.
The ticker below belongs to the native source snapshot. Company names, tickers and reporting structures may change; CIK identifies the source filer.
- Source filer CIK
- 1761612
- Ticker in native snapshot
- BCYC
- Reported numeric facts
- 73
- Units present
- USD · USD/shares